Moonlight Bio
Michael Karg is an experienced professional in clinical operations with a focus on oncology and cell therapy. Currently serving as Senior Director and Head of Clinical Operations at Moonlight Bio since July 2025, Karg previously held the position of Senior Director of Clinical Operations at Imugene Limited, overseeing a significant Oncology CAR T program. Prior experience includes roles at Precision BioSciences as Senior Director of Clinical Operations, where responsibilities encompassed managing clinical operations across various therapeutic areas, and at IQVIA as Director of Therapeutic Strategy, focusing on operational strategies and proposals. Karg began a career as a Project Director at PRA Health Sciences, where oversight of global clinical trials was a key responsibility. Educational qualifications include a Master’s degree in Clinical Research from Campbell University and a Bachelor’s degree in Chemistry from Gannon University.
This person is not in any teams
This person is not in any offices
Moonlight Bio
Moonlight Bio is a Seattle-based, preclinical stage biotech company pioneering the development of cutting-edge cell therapies for the treatment of cancer. Our team is comprised of highly collaborative individuals who are passionate about designing highly innovative technologies and candidates with the potential to transform the lives of cancer patients. Engaging across the full landscape of drug development, Moonlight’s team members are pursuing opportunities in discovery research, component design and screening, preclinical modeling, process and analytical development, translational and clinical studies, and partnerships necessary to enable and advance our core technologies. We believe in fostering a healthy work-life balance, and when we’re not busy in the lab, we enjoy the natural beauty and recreational activities that the Pacific Northwest has to offer. We love to collaborate! Reach out to us: info@moonlightbio.us